Efficacy of Biofeedback-Assisted Pelvic Muscle Floor Training and Electrical Stimulation on Women With Stress Urinary Incontinence

Stress Urinary Incontinence Clinical Trial

Official title:

Efficacy of Biofeedback-Assisted Pelvic Muscle Floor Training and Electrical Stimulation on Women With Different Pathophysiological Classifications of Stress Urinary Incontinence

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05272644
• Other study ID #: 109184-F
• Status: Recruiting
• Phase: N/A
• Start date: September 16, 2022
• Est. completion date: December 31, 2023

Study information

• Verified date: March 2023
• Source: Far Eastern Memorial Hospital
• Contact: Wen-Yih Wu
• Phone: 88689667000
• Email: wenyih[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The pathophysiological mechanism of stress urinary incontinence divides stress urinary incontinence into urethral hypermobility and intrinsic sphincter deficiency. Pelvic floor muscle exercise as first line therapy has been found to be extremely helpful in patients with mild to moderate forms of incontinence. Biofeedback uses an instrument to record the biological signals ( electrical activity) during a voluntary pelvic floor muscle contraction and present this information back to the woman in auditory or visual form. Electrical stimulation can aid in detecting pelvic floor muscles, and also promote the contraction of the pelvic floor muscles and strengthen the muscles. This study assumes that urinary incontinence women with different pathophysiological classifications receiving a pelvic floor muscle training with surface electromyographic biofeedback and electrical stimulation show differences in the strength of pelvic muscle and degree of symptoms improvement.

Description:

Participant will be assigned randomly to biofeedback-assisted pelvic floor muscle training (PFMT) group and biofeedback-assisted pelvic floor muscle training (PFMT) combined with electrical stimulation group. Each of the participant will receive the therapy for two months.The investigators expected that combination therapy will improve the compliance and severity of symptoms in women with stress urinary incontinence.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 128
• Est. completion date: December 31, 2023
• Est. primary completion date: December 31, 2023
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 20 Years to 85 Years

Eligibility

Inclusion Criteria:

1. overactivity bladder for more than 3 months

2. more then 20 year old,less then 85 year old and acceptable to receive vaginal examination

3. need to match schedule with the investigator's clinic for 45 times,followed by individual therapy, each takes about 30 to 60 minutes, a total of 8 weeks of pelvic floor muscle exercises

Exclusion Criteria:

1. Suffering from systemic neuromuscular diseases, such as stroke, spinal cord injury, peripheral neuropathy, etc.

2. Kidney disease

3. Liver disease

4. Patients with cardiac rhythm devices.

5. Insufficient cognitive function, unable to cooperate with pelvic floor muscle exercises.

6. Women during pregnancy.

7. Maternity within six weeks after delivery

Related Conditions & MeSH terms

• Enuresis
• Intrinsic Sphincter Deficiency
• Stress Urinary Incontinence
• Urethral Hypermobility
• Urinary Incontinence
• Urinary Incontinence, Stress

Intervention

Behavioral:
• surface electromyographic biofeedback assisted pelvic floor muscle training
participants will be doing surface electromyographic biofeedback assisted pelvic floor muscle training for 2 months
• surface electromyographic biofeedback and electrical stimulation
participants will be doing surface electromyographic biofeedback and electrical stimulation assisted pelvic floor muscle training for 2 months

Locations

Country	Name	City	State
Taiwan	Far Eastern Memorial Hospital	New Taipei City

Sponsors (1)

Lead Sponsor	Collaborator
Far Eastern Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	King's Health Questionnaire (KHQ)	KHQ has 3 parts consisting of 21 items. Part 1 contains general health perception and incontinence impact (one item each). Part 2 contains role limitations, physical limitations, social limitations (two items each), personal relationships, emotions (three items each) and sleep/energy (two items), severity measures (four items).Part 3 is considered as a single item and contains ten responses in relation to frequency, nocturia, urgency,urge, stress, intercourse incontinence, nocturnal enuresis,infections, pain, and difficulty in voiding. The 4 subscales scored between 1 (best) and 4 (worst) in part 1 and 2. The Symptom Severity scale is scored from 0 (best) to 3 (worst) in part 3 .	Time Frame: through study completion, an average of 8 weeks
Primary	A five-item Self-Assessment of Treatment (SAT)	to assess improvement and satisfaction with treatment, consists of 1 item. The scale scored between 1 (worst) and 5 (best ) .	Time Frame: through study completion, an average of 8 weeks.
Primary	Sandvik urinary incontinence severity test	The Sandvik test was developed by Sandvik et al to be used as a simple way to calculate severity of urinary incontinence in women. Answer the two questions below and your result will be displayed (Severity Index Score).	Time Frame: through study completion, an average of 8 weeks
Primary	Symptom Indexes for Stress Incontinence	assigning a grade based on a clinical history of incontinence: grade 1-only on Severe coughing, sneezing, lifting heavy objects, lifting heavy objects, jumping; grade 2-on walking or running; grade 3-on walking, doing housework (eg washing dishes, sweeping the floor), changing posture (eg from standing to squatting or sitting...);grade 4-on Resting state, such as turning over in bed	Time Frame: through study completion, an average of 8 weeks
Secondary	Introital and transvaginal ultrasound in the assessment of urogenital and pelvic floor dysfunction	the transducer is placed over the external urethral orifice with the transducer axis corresponding to the body axis Ultrasound assessment of the bladder and urethra starts in the midsagittal plane.; From this position, the transducer can be moved to the left or to the right for additional assessment of the periurethral tissue. The distance between bladder neck and line through the lower edge of the pubic symphysis, and the posterior urethrovesical angle ß (angle between urethral axis and bladder floor) are determined at rest and during contraction, coughing, and pressing. Changes in these parameters during contraction and pressing and in particular visual real-time ultrasound assessment serve to evaluate the reactivity of the pelvic floor muscles and the adequacy of the connective tissue supportive structures of the urogenital organs.	Time Frame: through study completion, an average of 8 weeks
Secondary	one-hour pad test	The test is carried out according to the recommendations of the International Continence Society and lasts for one hour and fifteen minutes. It consists in weighing the amount of urine retained in a sanitary napkin after the patient has completed a set of standard exercises, distributed over an hour.	Time Frame: through study completion, an average of 8 weeks
Secondary	change of electromyographic activity	Electromyographic activity of the pelvic floor muscles (PFMs) and the synergistic abdominal muscles (SAMs) during each session of PFMT(µV)	Time Frame: through study completion, an average of 8 weeks